{"id":922370,"date":"2026-10-09T23:06:10","date_gmt":"2026-10-09T23:06:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/922370\/"},"modified":"2026-10-09T23:06:10","modified_gmt":"2026-10-09T23:06:10","slug":"stopping-glp-1s-this-may-help-you-maintain-a-healthy-weight","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/922370\/","title":{"rendered":"Stopping GLP-1s? This May Help You Maintain a Healthy Weight"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"eager\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/10\/getty_2150019643_header_1296x728.jpg\" alt=\"Female sitting at a table, eating a healthy breakfast and scrolling on her phone\" class=\"css-bt1qz0\"\/><a class=\"icon-hl-pinterest css-foz1gx\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" data-event=\"Any Page|Image Pinterest Click|Icon Clicked\" data-element-event=\"OPEN|CONTENTBLOCK|Any Page|Article Body|BUTTON|Image Widget Pinterest Click|\" href=\"https:\/\/www.pinterest.com\/pin\/create\/button\/?url=https%3A%2F%2Fwww.healthline.com%2Fhealth-news%2Fwellness-apps-medically-tailored-meals-slow-weight-gain-after-glp-1s&amp;media=https%3A%2F%2Fmedia.post.rvohealth.io%2Fwp-content%2Fuploads%2F2026%2F10%2Fgetty_2150019643_header_1296x728.jpg&amp;description=Stopping%20GLP-1s%3F%20This%20May%20Help%20You%20Maintain%20a%20Healthy%20Weight\" title=\"Share on Pinterest\" data-pin-custom=\"true\" data-share-url=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/10\/getty_2150019643_header_1296x728.jpg\">Share on Pinterest<\/a>Recent research shows that structured support may help with weight maintenance after stopping GLP-1s. licensed miniseries \u00b7 E+\/GettyMost people regain a significant portion of the weight they lost within 1 year of stopping GLP-1 medications such as semaglutide (Wegovy) or tirzepatide (Zepbound).A small study found that structured support, including a digital weight management app or medically tailored meals, may help slow weight regain after stopping GLP-1 medications.Healthy eating habits, regular exercise, and ongoing medical support may help people maintain weight loss, while some may benefit from continuing GLP-1 medications long-term.<\/p>\n<p>In fact, previous research has shown that most people regain at least half of their lost weight within <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9542252\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">1 year<\/a> of stopping treatment, with weight regain often accelerating during the first <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC13043475\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">3\u20134 months<\/a>.<\/p>\n<p>However, a new study suggests that structured support, including a weight management app or medically tailored meals, may help slow weight regain after discontinuing GLP-1 medications.<\/p>\n<p>The small study, published October 7 in <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/osp4.70194\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">Obesity Science &amp; Practice<\/a>, found that participants who received either intervention regained significantly less weight over four months than those receiving usual care.<\/p>\n<p>The study included 39 adults with an average age of 50, an average weight of 189 pounds, and an average body mass index (BMI) of 31.4. <\/p>\n<p>All participants had lost more than 10% of their body weight while taking GLP-1 medications and had stopped treatment within the previous 30 days.<\/p>\n<p>All participants also completed questionnaires at the beginning and end of the study and used Bluetooth scales to track their weight at home throughout the four-month period. <\/p>\n<p>Researchers randomly assigned participants to one of the following three groups:<\/p>\n<p>Usual care<\/p>\n<p>Participants continued to receive care from their healthcare providers, which may include nutrition, exercise, and lifestyle counseling from a clinician or registered <a href=\"https:\/\/www.healthline.com\/health\/nutrition\/what-does-a-dietitian-do\" class=\"content-link css-kxhged\" rel=\"nofollow noopener\" target=\"_blank\">dietitian<\/a>. The type and amount of support varied depending on the provider\u2019s recommendations and available resources. The researchers did not provide any additional intervention.<\/p>\n<p>Digital weight management app<\/p>\n<p>Participants received a subscription to <a href=\"https:\/\/www.healthline.com\/nutrition\/noom-diet-review\" class=\"content-link css-kxhged\" rel=\"nofollow noopener\" target=\"_blank\">Noom<\/a>, an app that uses behavioral strategies to support weight loss and maintenance. These include tracking food intake, exercise, and weight, as well as educational lessons on the psychological, physiological, social, and environmental factors that influence eating behaviors.<\/p>\n<p>The app also provides tools to help users recognize and manage triggers that may lead to overeating. Participants were encouraged to use the app for at least 15 minutes daily, including completing lessons, logging food, and tracking their weight.<\/p>\n<p>Medically tailored meals<\/p>\n<p>These are typically nutrient-dense meals developed by registered dietitians to meet the nutritional needs of people with specific health conditions, such as <a href=\"https:\/\/www.healthline.com\/health\/ckd-stages\" class=\"content-link css-kxhged\" rel=\"nofollow noopener\" target=\"_blank\">chronic kidney disease<\/a> or uncontrolled <a href=\"https:\/\/www.healthline.com\/health\/type-2-diabetes\" class=\"content-link css-kxhged\" rel=\"nofollow noopener\" target=\"_blank\">type 2 diabetes<\/a>.<\/p>\n<p>For this study, participants in this group selected 10 portion-controlled, \u201cweight wellness\u201d meals each week from more than 70 options, which were delivered to their homes.<\/p>\n<p>After four months, participants who received either medically tailored meals or access to the digital weight management app experienced significantly less weight regain than those receiving usual care.<\/p>\n<p>The estimated weight regain was 10.75% of body weight in the usual-care group, compared with 3.6% in the Noom group and 3.58% in the medically tailored meals group.<\/p>\n<p>Although participants in all three groups regained weight, the findings suggest that structured nutritional or behavioral support may help limit weight regain after stopping GLP-1 medications.<\/p>\n<p>\u201cThese findings highlight the benefits of ongoing support for patients on a weight loss journey,\u201d said <a href=\"https:\/\/www.memorialcare.org\/providers\/mir-b-ali\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">Mir Ali<\/a>, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA. Ali wasn\u2019t involved in the study.<\/p>\n<p><a href=\"https:\/\/www.medicalofficesofmanhattan.com\/our-team\/denise-pate-md\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">Denise Pate<\/a>, MD, a board certified internist with Medical Offices of Manhattan who was also not involved in the study, told Healthline that the findings are significant \u201cbecause they show that obesity management is multifactorial, not only medication, but the combination of types of meals and behavioral change all play a role.\u201d<\/p>\n<p>However, because this was a small, four-month study, larger, longer-term trials are needed to determine whether these approaches can help people maintain weight loss over time after stopping GLP-1 medications.<\/p>\n<p>Ali noted that <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12361690\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">research<\/a> suggests GLP-1 medications are most effective for weight management when taken long-term.<\/p>\n<p>Pate agreed, emphasizing that obesity is not always recognized as a chronic condition that may require ongoing treatment.<\/p>\n<p>\u201cI feel that the medical community, insurance, and the population as a whole have yet to fully accept obesity as a chronic medical condition, which it most definitely is for a large part of patients. For this reason, I think patients should stay on these medications long term if needed,\u201d she said.<\/p>\n<p>\u201cGLP-1 medications are highly effective tools for transitioning to a healthier diet and lifestyle, which for most people may require long-term use,\u201d Ali added.<\/p>\n<p>Pate explained that one of the goals of GLP-1 medications is to help people eat smaller portions by recognizing when they feel full and stopping when they do.<\/p>\n<p>\u201cI tell my patients from the start, this is the goal,\u201d she said, adding that she hopes patients will retain those habits after stopping treatment.<\/p>\n<p>Ali recommended maintaining a balanced diet rich in protein and vegetables while limiting added sugars and refined carbohydrates. <\/p>\n<p>He added that tracking apps and regular follow-up appointments with a healthcare professional or registered dietitian may also help people maintain their progress.<\/p>\n<p>\u201cPatients need to understand that the GLP medication is not a miracle drug, although with the dramatic weight loss, it can be perceived as such. It is only a tool to be used in conjunction with an exercise routine as well as a healthy diet,\u201d Pate said.<\/p>\n","protected":false},"excerpt":{"rendered":"Share on PinterestRecent research shows that structured support may help with weight maintenance after stopping GLP-1s. licensed miniseries&hellip;\n","protected":false},"author":2,"featured_media":922371,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[64,63,137,490],"class_list":["post-922370","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-au","tag-australia","tag-health","tag-medication"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/922370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=922370"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/922370\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/922371"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=922370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=922370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=922370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}